Peer Reviewed Scientific Studies

Peer-Reviewed Scientific Publications On High-Energy Extracorporeal Shock Wave for Musculoskeletal Conditions

* Articles with an asterisk indicate a use that has not been approved or cleared by the U.S. Food and Drug Administration. PulseVet is providing this information in an educational format and to provide a complete listing of high energy ESWT articles and makes no claims as to the effectiveness of OssaTron® treatments, other than those approved by the FDA.

Indication

Article Title

Journal Reference

Author

Key Points

Patellar Tendinopathy*

Extracorporeal Shock Wave for Chronic Patellar Tendinopathy

Am J Sports Med. 2007 Feb 16;ePub.

C. Wang, MD

At 2 - 3 year follow up, 90% of patients treated with the OssaTron reported excellent to good results. Only 50% of control group patients reported good results. Recurrance rate was 13% in the ESWT group and 50% in the control group.

Stress Fracture*

Extracorporeal Shock Wave Therapy for Resistant Stress Fracture in Athletes

Am J Sports Med. 2007 Feb 9;ePub.

Taki, M et al

Athletes ages 17 to 22 with resistant (chronic 6-12 months) stress fractures were treated with ESWT. Athletes were able to resume normal sports activities soon after treatment.

Actue Fractures*

The Effects of Extracorporeal Shock Wave in Acute High-Energy Long Bone Fractures of the Lower Extremity

Arch Orthop Trauma Surg 2006 Oct;ePub.

Wang, CJ et al

High-Energy fracture patients were treated with ESWT during their inital surgical fixation during the fractures acute fracture. At 12 months, the rate of non-union was 11% in teh ESWT group vs. 20% in the control group.

Plantar Fasciitis

Long-Term Results of Extracorporeal Shock Wave Technology for Plantar Fasciitis

Am J Sports Med. 2006 Apr;34(4):592-6.

C. Wang, MD

Patients were followed 5 - 6 years after ESWT and reported 82.7% good to excellent results (69.1% excellent, 13.6% good). The study control group using conservative therapies reported only 55% good results after the same amount of time.

Plantar Fasciitis

Effectiveness of Extracorporeal Shock Wave Technology in 353 Patients with ;Chronic Plantar Fasciitis

The Journal of the American Podiatric Medical Association Volume 95 No.6 November/December 2005

D. Norris, MD

Post-treatment survey of 353 patients reporting 76% of patients experiencing 43% decline in pain and 66% of patients experiencing 44% increase in mobility. 69% of patients indicated they would recommend the high energy extracorporeal shock wave procedure.

Plantar Fasciitis

Treatment for Osteonecrosis for the Femoral Head: Comparison of Extracorporeal Shock Waves with Core Decompression and Bone-Grafting

The Journal of Bone and Joint Surgery November 2005

C. Wang, MD

Extracorporeal Shock Wave Treatment appeared to be more effective than core decompression and nonvascularized fibular grafting for providing short-term pain relief for patients affected by early stages of osteonecrosis of the femoral head.

Plantar Fasciitis

Electrohydraulic High-Energy Shock- Wave Treatment for Chronic Proximal Plantar Fasciitis

Journal of Bone and Joint Surgery, Inc. Volume 86-A, Number 10, October 2004

J. Ogden, MD

Reports that high-energy shock waves to the heel is a safe and effective non-invasive method to treat chronic plantar fasciitis with outcomes maintained one year and up to five years.

Animal Study*

Effect of Shock Wave Therapy on Patellar Tendonopathy in a Rabbit Model

Journal of Orthopaedic Research, 22 (2004) pp. 221-227

R. Hsu, MD

Histological exams at 4 and 16 weeks after ESWT found increased tenocyte production with neovascularization at 16 weeks.

Plantar Fasciitis

Symptom Duration of Plantar Fasciitis and the Effectiveness of Orthotripsy

Foot & Ankle International, Vol. 24,No. 12/December 2003

R. Alvarez, MD

Discusses that patients have a slightly better outcome if they have had chronic plantar fasciitis for 1-2 years compared to patients who had been diagnosed longer. An important secondary finding was that one hundred and twenty three patients were followed 2-5 years and their outcomes were maintained.

Plantar Fasciitis

Effect of Extracorporeal Shock Waves on Calcaneal Bone Spurs

Foot & Ankle International, Vol. 24,No. 12/December 2003

G. Lee, MD

Reviews 308 patients treated with ESWT and finds that the presence or absence of heel spurs does not affect the likelihood of a positive outcome. 82% of patients with heel spurs had excellent to good outcomes and 79% of patients without heel spurs reported excellent to good outcomes.

Rotator Cuff Tendonitis*

Extracorporeal Shock Wave Therapy for the Treatment of Chronic Calcifying Tendonitis of the Rotator Cuff

JAMA, Nov. 19, 2003

L. Gerdesmeyer, MD

This study discusses that high energy shock wave application is more effective than placebo and significantly more effective than low energy application. At 12 months the high-energy group had 86% complete resolution, compared to the low-energy and sham subjects who at 12 months were only 37% and 25% respectively.

Animal Study*

Shock Wave Therapy Induces Neovascularization at the Tendon-Bone Junction: A Study in Rabbits

Journal of Orthopaedic Research, 21 (2003) pp. 984-989

C. Wang, MD

Article finds that "the mechanism of shock wave therapy involved the early release of angiogenic growth factors (eNOS and VEGF) and subsequent induction of neovascularization and tissue proliferation. The neovascularizatoin may play a role in pain relief of tendonitis and the repair of chronically inflamed tendon tissues at the tendon-bone junction."

Lateral Epicondylitis

Shock Wave Therapy for Patients with Lateral Epicondylitis of the Elbow: A One- to Two- Year Follow-up Study

The American Journal of Sports Medicine, Vol. 30, No. 3, 2002

C. Wang, MD

One to two year study following 43 patients with lateral epicondylitis reporting 90.9% complaint-free or significantly better results with OssaTron® Shock Wave Technology. Control group patients who received sham treatment reported no change.

Plantar Fasciitis

Extracorporeal Shock Wave Therapy for Chronic Proximal Plantar Fasciitis

Clinics in Podiatric Medicine and Surgery, October 2002, Vol. 19, No. 4

W. Strash, DPM, FACFAS

Article reporting 74% excellent to good results after twelve weeks and 87% excellent to very good results after 6 months with 48 human feet with high energy ESWT.

Plantar Fasciitis

Extracorporeal Shock Wave Therapy (ESWT) for the Treatment of Chronic Plantar Fasciitis: Indications, Protocol, and a Comparison of Results to Fasciotomy

The Journal of Foot & Ankle Surgery, June 2002, Vol. 41, Number 3

L. Weil, Jr., DPM

Study with mean follow-up of 8.4 months reporting 82% good to excellent results with high-energy electrohydraulic ESWT.

Plantar Fasciitis

Shock Wave Therapy for Patients with Plantar Fasciitis: A One-Year Follow-up Study

Foot & Ankle International, March 2002, Vol. 23, Nov. 3

C. Wang, MD

One year follow-up study reporting greater than 93% success and retention post high-energy OssaTron® ESWT.

Plantar Fasciitis

Preliminary Results on the Safety and Efficacy of the OssaTron® for Treatment of Plantar Fasciitis

Foot & Ankle International, March 2002, Vol. 23 No. 3

R. Alvarez, MD

Study reporting safety and efficacy success with 18 out of 20 patients improved/pain free after ESWT with the high-energy OssaTron® device.

Plantar Fasciitis

Shock Wave Therapy for Chronic Plantar Fasciitis: A Meta-Analysis

Foot & Ankle International, April 2002, Vol. 23 No.4

J. Ogden, MD

Analysis reviewed 20 studies on shock wave for plantar fasciitis and concluded that the studies demonstrated that ESWT should be considered before any surgical

intervention for plantar fasciitis.

Animal Study*

Neovascularization at the Tendon-Bone Junction: An Experiment in Dogs

The Journal of Foot and Ankle Surgery, Vol. 41, No. 1, January/February 2002

C. Wang, MD

Discusses the effect of shock waves in generating neovascularization and muscularized vessels when shock waves were applied to dogs using the OssaTron®.

Nonunion - Delayed Union*

Extracorporeal Shock Wave Therapy of Nonunion or Delayed Osseous Union

Clinical Orthopaedics and Related Research, Number 387, pp. 90-94, June, 2001

W. Schaden, MD

In 75.7% of treated patients, one treatment with shock waves resulted in bony consolidation with a simultaneous decrease in symptoms.

Nonunion*

Treatment of Nonunions of Long Bone Fractures with Shock Waves

Clinical Orthopaedics and Related Research, No. 387, June 2001

C. Wang, MD

72 subjects with long bone nonunions were studied - 40% had boney union at 3 months, 60.9% at 6 months and 80% at 12 months post-ESWT with the OssaTron®.

Plantar Fasciitis

Treatment of Painful Heel Syndrome With Shock Waves

Clinical Orthopaedics and Related Research, Number 387, pp. 41-46, June, 2001

H. Chen, MD

Study reporting 73.5% excellent to good results with 68 heels post-ESWT after twelve weeks and 87% excellent to good results with 54 heels with six months follow-up.

Lateral Epicondylitis

Treatment of Lateral Epicondylitis of the Elbow with Shock Waves

Clinical Orthopaedics and Related Research, Number 387, pp. 60-67, June, 2001

J. Ko, MD

Article demonstrates that healing effect from ESWT is time dependent. 57.9% reporting excellent to good responses at 12 weeks which increased to 73% excellent to good response at 24 weeks post-ESWT.

Plantar Fasciitis

Shock Wave Therapy of Chronic Proximal Plantar Fasciitis

Clinical Orthopaedics and Related Research, Number 387, pp. 47-59, June, 2001

J. Ogden, MD

OssaTron® FDA clinical study involving 302 patients reporting 74% excellent to good results post high energy ESWT.

Plantar Fasciitis

Treatment of Painful Heels Using Extracorporeal Shock Wave

J Formos Med Assoc. 2000, Vol. 99, No. 7

C. Wang, MD

Study reporting 81% excellent to very good results involving 58 patients after 12 weeks with high energy OssaTron® ESWT.

* Articles with an asterisk indicate a use that has not been approved or cleared by the U.S. Food and Drug Administration. PulseVet is providing this information in an educational format and to provide a complete listing of high energy ESWT articles and makes no claims as to the effectiveness of OssaTron® treatments, other than those approved by the FDA.

 

Pulse Veterinary Technologies, LLC ●  2300 Lakeview Parkway  ●  Suite 700  ●  Alpharetta, GA 30009  ●  Customer Service: (800) 245-4417